Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition.

MLA

Correa, I., and T. Plunkett. “Update on HER-2 as a Target for Cancer Therapy: HER2/Neu Peptides as Tumour Vaccines for T Cell Recognition.” Breast Cancer Research : BCR, vol. 3, no. 6, 2001, pp. 399–403. EBSCOhost, https://doi.org/10.1186/bcr330.

APA

Correa, I., & Plunkett, T. (2001). Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition. Breast Cancer Research : BCR, 3(6), 399–403. https://doi.org/10.1186/bcr330

Chicago

Correa, I, and T Plunkett. 2001. “Update on HER-2 as a Target for Cancer Therapy: HER2/Neu Peptides as Tumour Vaccines for T Cell Recognition.” Breast Cancer Research : BCR 3 (6): 399–403. doi:10.1186/bcr330.